GENDER DIFFERENCES IN HEPATOCELLULAR CARCINOMA (HCC) SURVEILLANCE ADHERENCE PATTERNS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN A MULTICENTER ACADEMIC AND COMMUNITY COHORT STUDY

被引:0
|
作者
Nguyen, L. [1 ]
Wang, C. [1 ]
Hoang, J. [2 ]
Trinh, H. N. [3 ]
Li, J. [4 ]
Zhang, J. Q. [5 ]
Nguyen, M. [2 ]
机构
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
[3] San Jose Gastroenterol, San Jose, CA USA
[4] Palo Alto Med Fdn, Gastroenterol, Mountain View, CA USA
[5] Chinese Hosp, San Francisco, CA USA
关键词
D O I
10.1016/S0168-8278(15)30790-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P0584
引用
收藏
页码:S535 / S535
页数:1
相关论文
共 50 条
  • [41] PAGE-B: RISK SCORE FOR HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS RECEIVING ENTECAVIR (ETV) OR TENOFOVIR (TDF)
    Papatheodoridis, G. V.
    Dalekos, G.
    Sypsa, V.
    Yurdaydin, C.
    Buti, M.
    Goulis, J.
    Arends, P.
    Manolakopoulos, S.
    Mangia, G.
    Gatselis, N.
    Keskin, O.
    Savvidou, S.
    Hansen, B. E.
    Papaioannou, C.
    Galanis, K.
    Idilman, R.
    Colombo, M.
    Esteban, R.
    Janssen, H. L. A.
    Lampertico, P.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S435 - S435
  • [42] FIB4 Score and Gender Predict the Incidence of Hepatocellular Carcinoma (HCC) among Patients with Chronic Hepatitis C Virus (HCV) Infection: Chronic Hepatitis Cohort Study (CHeCS)
    Xu, Fujie
    Xing, Jian
    Moorman, Anne C.
    Gordon, Stuart C.
    Rupp, Loralee B.
    Lu, Mei
    Spradling, Philip R.
    Teshale, Eyasu H.
    Boscarino, Joseph A.
    Vijayadeva, Vinutha
    Schmidt, Mark A.
    HEPATOLOGY, 2014, 60 : 905A - 905A
  • [43] Gender differences in hepatocellular carcinoma : is it all due to adherence to surveillance? A study of 1, 716 patients over 3 decades
    Liou, Wei-Lun
    Tan, Terence
    Chen, Kaina
    Goh, Boon Bee George
    Chang, Pik Eu Jason
    Tan, Chee-Kiat
    JOURNAL OF HEPATOLOGY, 2022, 77 : S919 - S920
  • [44] Gender survival differences in hepatocellular carcinoma: Is it all due to adherence to surveillance? A study of 1716 patients over three decades
    Liou, Wei-Lun
    Tan, Terence J-Y.
    Chen, Kaina
    Goh, George B-B.
    Chang, Jason P-E.
    Tan, Chee-Kiat
    JGH OPEN, 2023, 7 (05): : 377 - 386
  • [45] Risk Differences of Hepatocellular Carcinoma (HCC) Among Patients with Chronic Hepatitis C (CHC) of Different Viral Genotypes: a Historical Cohort Study in the United States
    Jin, Mingjuan
    Zhao, Changqing
    Hoang, Joseph K.
    Nguyen, Nghia H.
    Le, An K.
    Chang, Christine Y.
    Le, Richard H.
    Kutsenko, Alina
    Yasukawa, Lee Ann
    Zhang, Jian Q.
    Weber, Susan C.
    Nguyen, Mindie H.
    HEPATOLOGY, 2015, 62 : 392A - 392A
  • [46] Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Goulis, Ioannis
    Arends, Pauline
    Buti, Maria
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostas
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    HEPATOLOGY, 2013, 58 : 302A - 303A
  • [47] Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
    Matsumoto, A
    Tanaka, E
    Rokuhara, A
    Kiyosawa, K
    Kumada, H
    Omata, M
    Okita, K
    Hayashi, N
    Okanoue, T
    Iino, S
    Tanikawa, K
    HEPATOLOGY RESEARCH, 2005, 32 (03) : 173 - 184
  • [48] HTERT PROMOTER GENE POLYMORPHISM AND THE RISK OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CHRONIC HEPATITIS B
    Park, J. Y.
    Chang, H. Y.
    Ahn, S. H.
    Lee, J. M.
    Kim, D. Y.
    Lee, K. S.
    Chon, C. Y.
    Moon, Y. M.
    Han, K. -H.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S345 - S345
  • [49] HIGHER HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C (CHC) PATIENTS AFTER HEPATITIS C VIRUS (HCV) CURE COMPARED TO TREATED CHRONIC HEPATITIS B (CHB): RESULTS FROM A MULTINATIONAL REAL-WORLD COHORT OF PATIENTS WITH CIRRHOSIS
    Park, Jiyoon
    Tran, Sally
    Ogawa, Eiichi
    Huang, Chung-Feng
    Toyoda, Hidenori
    Chen, Chien Hung
    Yeh, Ming-Lun
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Kawashima, Keigo
    Preda, Carmen
    Istratescu, Doina
    Yasuda, Satoshi
    Nozaki, Akito
    Chuma, Makoto
    Oh, Hyunwoo
    Shim, Jae-Jun
    Jeong, Soung Won
    An, Jihyun
    Ahn, Sang Bong
    Kim, Sung Eun
    Yoon, Eileen
    Lee, Han Ah
    Kim, Hyoung Su
    Cho, Yong Kyun
    Uojima, Haruki
    Trinh, Huy
    Atsukawa, Masanori
    Itokawa, Norio
    Okubo, Tomomi
    Abe, Hiroshi
    Lee, Dong Hyun
    Jun, Mi Jung
    Landis, Charles
    Liu, Joanne
    Enomoto, Masaru
    Watanabe, Tsunamasa
    Ji, Fanpu
    Wang, Wenjun
    Yu, Li
    Xie, Qing
    Fukunishi, Shinya
    Asai, Akira
    Yokohama, Keisuke
    Ishikawa, Toru
    Liu, Li
    Li, Junyi
    Takahashi, Hirokazu
    Inoue, Kaori
    Eguchi, Yuichiro
    HEPATOLOGY, 2022, 76 : S377 - S379
  • [50] Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection"
    Chayanupatkul, Maneerat
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 886 - 887